Liddle; Christopher

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liddle; Christopher.The latest application filed is for "analogs of fexaramine and methods of making and using".

Company Profile

1.16.15

Liddle; Christopher - Chertswood AU
Liddle; Christopher - Tura Beach AU
Liddle; Christopher - Chatswood N/A AU
Liddle; Christopher - New South Wales AU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Analogs of fexaramine and methods of making and using Grant 11,440,889 - Evans , et al. September 13, 2	2022-09-13
Analogs Of Fexaramine And Methods Of Making And Using App 20210147365 - Evans; Ronald M. ; et al.	2021-05-20
Analogs of fexaramine and methods of making and using Grant 10,815,203 - Evans , et al. October 27, 2	2020-10-27
Analogs Of Fexaramine And Methods Of Making And Using App 20200123113 - Evans; Ronald M. ; et al.	2020-04-23
Analogs of fexaramine and methods of making and using Grant 10,450,277 - Evans , et al. Oc	2019-10-22
Analogs of fexaramine and methods of making and using Grant 10,301,268 - Evans , et al.	2019-05-28
Vitamin D receptor/SMAD genomic circuit gates fibrotic response Grant 10,238,667 - Ding , et al.	2019-03-26
Analogs Of Fexaramine And Methods Of Making And Using App 20190084939 - Evans; Ronald M. ; et al.	2019-03-21
FXR agonists and methods for making and using Grant 10,077,268 - Evans , et al. September 18, 2	2018-09-18
Vitamin D Receptor/smad Genomic Circuit Gates Fibrotic Response App 20180071318 - Ding; Ning ; et al.	2018-03-15
Vitamin D receptor/SMAD genomic circuit gates fibrotic response Grant 9,872,866 - Ding , et al. January 23, 2	2018-01-23
Analogs Of Fexaramine And Methods Of Making And Using App 20170066724 - Evans; Ronald M. ; et al.	2017-03-09
Fxr Agonists And Methods For Making And Using App 20160376279 - Evans; Ronald M. ; et al.	2016-12-29
Vitamin D Receptor/smad Genomic Circuit Gates Fibrotic Response App 20160106762 - Ding; Ning ; et al.	2016-04-21
Xenobiotic related induction of gene expression Grant 9,029,336 - Liddle , et al. May 12, 2	2015-05-12
Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation Grant 8,629,318 - Liddle , et al. January 14, 2	2014-01-14
Use of vitamin D receptor agonists, ligands, and precursors to treat pancreatic fibrosis Grant 8,318,708 - Evans , et al. November 27, 2	2012-11-27
Transgenic Animals for Analyzing CYP3A4 Cytochrome P450 Gene Regulation App 20120171690 - Liddle; Christopher ; et al.	2012-07-05
Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation Grant 8,088,968 - Liddle , et al. January 3, 2	2012-01-03
Use Of Vitamin D Receptor Agonists And Precursors To Treat Fibrosis App 20110014126 - Evans; Ronald M. ; et al.	2011-01-20
Xenobiotic Related Induction Of Gene Expression App 20100146652 - LIDDLE; Christopher ; et al.	2010-06-10
Xenobiotic related induction of gene expression Grant 7,638,614 - Liddle , et al. December 29, 2	2009-12-29
Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation App 20090307785 - Liddle; Christopher ; et al.	2009-12-10
Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation App 20090288181 - LIDDLE; Christopher ; et al.	2009-11-19
Use Of Vitamin D Receptor Agonists And Precursors To Treat Fibrosis App 20090209500 - EVANS; RONALD M. ; et al.	2009-08-20
P450 gene regulation Grant 7,531,712 - Liddle , et al. May 12, 2	2009-05-12
Xenobiotic related induction of gene expression App 20060105385 - Liddle; Christopher ; et al.	2006-05-18
Cytochrome P450 transcriptional enhancer nucleic acid molecule Grant 6,984,489 - Liddle , et al. January 10, 2	2006-01-10
Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation App 20050076397 - Liddle, Christopher ; et al.	2005-04-07

Company Registrations

SEC

0001745779

LIDDLE CHRISTOPHER

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.